Targeting of GSDMD sensitizes HCC to anti-PD-1 by activating cGAS pathway and downregulating PD-L1 expression DOI Creative Commons
Tingting Lv,

Xiaofeng Xiong,

Wei Yan

et al.

Journal for ImmunoTherapy of Cancer, Journal Year: 2022, Volume and Issue: 10(6), P. e004763 - e004763

Published: June 1, 2022

Background Gasdermin D (GSDMD) is well known as a downstream of inflammasomes. However, the roles GSDMD itself in hepatocellular carcinoma (HCC) remain unclear. Methods Two independent cohorts patients with HCC were analyzed to evaluate pathological relevance GSDMD/pTBK1/PD-L1. knockout (GSDMD-/-) mice, Alb-Cre mice administered an adeno-associated virus (AAV) vector that expressed gasdermin-N domain (AAV9-FLEX-GSDMD-N) and their wild-type littermates used induce hepatocarcinogenesis or metastatic HCC. Combination anti-programmed cell death protein-1 (PD-1) inhibitor dimethyl fumarate (DMF) was test for improved therapeutic efficacy. RNA sequencing explore mechanisms how promoted progression. Results The expression GSDMD-N upregulated tissues positive indicated grim prognosis. Diethylnitrosamine/carbon tetrachloride thioacetamide-treated GSDMD-/- exhibited decreased liver tumors. In contrast, AAV9-FLEX-GSDMD-N hepatocarcinogenesis. manifested impacted cyclic GMP-AMP synthase (cGAS) pathway immune-associated pathway. damped cGAS activation by promoting autophagy via outputting potassium (K+) programmed ligand-1 (PD-L1) histone deacetylases/signal transducer activator transcription 1 (STAT1)-induced transactivation PD-L1 importing calcium (Ca2+). High Mobility Group Box 1/toll-like receptor 4 (TLR4)/caspase-1 contributed overexpression cleavage GSDMD. Anti-PD-1 combining DMF largely impaired progression metastasis. Conclusions Targeting could promote interferons through inactivation downregulated expression. Therefore, combined anti-PD-1 might serve effective treatment option upregulation.

Language: Английский

Ferroptosis at the intersection of lipid metabolism and cellular signaling DOI Creative Commons
Deguang Liang, Alexander M. Minikes, Xuejun Jiang

et al.

Molecular Cell, Journal Year: 2022, Volume and Issue: 82(12), P. 2215 - 2227

Published: April 6, 2022

Language: Английский

Citations

687

Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications DOI
Qing‐zhang Tuo, Shuting Zhang, Peng Lei

et al.

Medicinal Research Reviews, Journal Year: 2021, Volume and Issue: 42(1), P. 259 - 305

Published: May 6, 2021

Abstract Ischemic stroke caused by arterial occlusion is the most common type of stroke, which among frequent causes disability and death worldwide. Current treatment approaches involve achieving rapid reperfusion either pharmacologically or surgically, both are time‐sensitive; moreover, blood flow recanalization often ischemia/reperfusion injury. However, even though neuroprotective intervention urgently needed in event exact mechanisms neuronal during ischemic still unclear, consequently, capacity for drug development has remained limited. Multiple cell pathways implicated pathogenesis stroke. Here, we have reviewed these potential pathways, including intrinsic extrinsic apoptosis, necroptosis, autophagy, ferroptosis, parthanatos, phagoptosis, pyroptosis. We also latest results pharmacological studies on summarized emerging targets with a focus clinical trials. These observations may help to further understand pathological events bridge gap between basic translational research reveal novel interventions.

Language: Английский

Citations

469

New opportunities and challenges of natural products research: When target identification meets single-cell multiomics DOI
Yuyu Zhu, Zijun Ouyang, Haojie Du

et al.

Acta Pharmaceutica Sinica B, Journal Year: 2022, Volume and Issue: 12(11), P. 4011 - 4039

Published: Aug. 27, 2022

Language: Английский

Citations

264

Cell death pathways: intricate connections and disease implications DOI

Matthias Kist,

Domagoj Vucic

The EMBO Journal, Journal Year: 2021, Volume and Issue: 40(5)

Published: Jan. 13, 2021

Language: Английский

Citations

246

The interaction between ferroptosis and inflammatory signaling pathways DOI Creative Commons
Yue Chen, Zemin Fang, Xin Yi

et al.

Cell Death and Disease, Journal Year: 2023, Volume and Issue: 14(3)

Published: March 21, 2023

Abstract Ferroptosis is an iron-dependent regulated cell death driven by excessive lipid peroxidation. Inflammation one common and effective physiological event that protects against various stimuli to maintain tissue homeostasis. However, the dysregulation of inflammatory responses can cause imbalance immune system, dysfunction death. Recent studies have pointed out activation inflammation, including multiple inflammation-related signaling pathways, lead ferroptosis. Among related signal transduction we focused on five classical namely, JAK-STAT, NF-κB, inflammasome, cGAS-STING MAPK expounded their roles in To date, many agents shown therapeutic effects ferroptosis-related diseases modulating aforementioned pathways vivo vitro. Moreover, regulatory these iron metabolism peroxidation been described detail, contributing further understanding pathophysiological process Taken together, targeting inflammation will provide appropriate ways intervene ferroptosis diseases.

Language: Английский

Citations

234

Apoptotic cell death in disease—Current understanding of the NCCD 2023 DOI Open Access
Ilio Vitale, Federico Pietrocola, Emma Guilbaud

et al.

Cell Death and Differentiation, Journal Year: 2023, Volume and Issue: 30(5), P. 1097 - 1154

Published: April 26, 2023

Language: Английский

Citations

222

The therapeutic potential of targeting regulated non-apoptotic cell death DOI
Kamyar Hadian, Brent R. Stockwell

Nature Reviews Drug Discovery, Journal Year: 2023, Volume and Issue: 22(9), P. 723 - 742

Published: Aug. 7, 2023

Language: Английский

Citations

182

Identity, structure, and function of the mitochondrial permeability transition pore: controversies, consensus, recent advances, and future directions DOI Creative Commons
Paolo Bernardi, Christoph Gerle, Andrew P. Halestrap

et al.

Cell Death and Differentiation, Journal Year: 2023, Volume and Issue: 30(8), P. 1869 - 1885

Published: July 17, 2023

The mitochondrial permeability transition (mPT) describes a Ca

Language: Английский

Citations

167

Heme Oxgenase-1, a Cardinal Modulator of Regulated Cell Death and Inflammation DOI Creative Commons
Stefan W. Ryter

Cells, Journal Year: 2021, Volume and Issue: 10(3), P. 515 - 515

Published: Feb. 28, 2021

Heme oxygenase catalyzes the rate-limiting step in heme degradation order to generate biliverdin, carbon monoxide (CO), and iron. The inducible form of enzyme, oxygenase-1 (HO-1), exerts a central role cellular protection. substrate, heme, is potent pro-oxidant that can accelerate inflammatory injury promote cell death. HO-1 has been implicated as key mediator tissue injury, validated preclinical models acute lung sepsis. A large body work also cytoprotective molecule against various forms death, including necrosis, apoptosis newly recognized regulated death (RCD) programs such necroptosis, pyroptosis, ferroptosis. While antiapoptotic potential its reaction product CO regulation extensively characterized, relatively fewer studies have explored regulatory other necrotic RCD (i.e., necroptosis ferroptosis). may provide anti-inflammatory protection or pyroptosis. In contrast, ferroptosis, play pro-death via enhancing iron release. co-regulation autophagy, homeostatic program for catabolic recycling proteins organelles. autophagy primarily associated with survival, occurrence coincide programs. This review will summarize roles products co-regulating programs, implication both protective detrimental responses, emphasis on how these impact candidate therapeutic target disease.

Language: Английский

Citations

159

Mitochondria-associated programmed cell death as a therapeutic target for age-related disease DOI Creative Commons
Thanh Tùng Nguyễn, Shibo Wei, Ha Nguyen Thi Thu

et al.

Experimental & Molecular Medicine, Journal Year: 2023, Volume and Issue: 55(8), P. 1595 - 1619

Published: Aug. 23, 2023

Abstract Mitochondria, ubiquitous double-membrane-bound organelles, regulate energy production, support cellular activities, harbor metabolic pathways, and, paradoxically, mediate cell fate. Evidence has shown mitochondria as points of convergence for diverse death-inducing pathways that trigger the various mechanisms underlying apoptotic and nonapoptotic programmed death. Thus, dysfunctional eventually lead or contribute to age-related diseases, such neurodegenerative, cardiovascular diseases. mitochondrion-associated death-based treatments show great therapeutic potential, providing novel insights in clinical trials. This review discusses mitochondrial quality control networks with activity triggered by stimuli maintain homeostasis via mitohormesis, unfolded protein response, mitophagy. The also presents details on forms mitochondria-associated death, including apoptosis, necroptosis, ferroptosis, pyroptosis, parthanatos, paraptosis, highlights their involvement disease pathogenesis, collectively suggesting directions further research.

Language: Английский

Citations

129